Retraction Retraction dated 2023-10-10
Click to view Retraction: https://doi.org/10.1007/s13311-023-01448-3
Retraction Retraction dated 2023-10-01
Click to view Retraction: https://doi.org/10.1007/s13311-023-01448-3
Updates are available Correction dated 2021-10-01
Click to view Correction: https://doi.org/10.1007/s13311-021-01163-x
Updates are available Erratum dated 2021-10-01
Click to view Erratum: https://doi.org/10.1007/s13311-021-01163-x
-
Authors
Rao, Shalini S.
Lago, Larissa
Volitakis, Irene
Shukla, Jay J.
McColl, Gawain
Finkelstein, David I.
Adlard, Paul A. https://orcid.org/0000-0003-0547-5307
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-020-00972-w
CrossRef DOI link to the associated document: https://doi.org/10.1007/s13311-021-01163-x
Content Type: article
Copyright: Copyright © 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.
